Session Details
[O-01]Oral Session 01 Cerebrovascular disease 1
Wed. May 21, 2025 3:35 PM - 5:05 PM JST
Wed. May 21, 2025 6:35 AM - 8:05 AM UTC
Wed. May 21, 2025 6:35 AM - 8:05 AM UTC
第03会場(大阪国際会議場10F 会議室1003)
Chairs: Masafumi Ihara(Department of Neurology, National Cerebral and Cardiovascular Center, Japan), Shuhei Okazaki(NHO Osaka National Hospital, Department of Neurology, Japan)
[O-01-6]Single-Cell RNA Sequencing Reveals Stroke-Caused Temporal Changes in Oligodendrocyte Precursor Cells
Kazuto Tsukita1,2, Yasuhiro Kuwata1, Ken Yasuda1, Akihiro Kikuya1, Naoki Takayama1, Narufumi Yanagida1, Kimitoshi Kimura1, Ryosuke Takahashi1,3, Riki Matsumoto1, Takakuni Maki1 (1.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan, 2.Advanced Comprehensive Research Organization, Teikyo University, Japan, 3.Kyoto University Research Administration Center, Kyoto, Japan, Japan)
所属・役職:
京都大学大学院医学研究科 臨床神経学 特定助教
帝京大学 先端統合研究機構特任研究員
学歴:
2013年 京都大学医学部医学科 卒業
2022年 京都大学大学院 博士課程 修了
研究:
パーキンソン病を含めた神経疾患全般に対して、大規模コホートやバイオインフォマティクスを駆使しつつ、母の研究室にて従事している上皮バリア分子生物学の実験経験も融合し、「実臨床に役に立つ」 & 「病態を解明する」成果を目指す。
主要論文10編:#筆頭著者, *責任著者
<パーキンソン病関連>
1. Kikuya A#, Tsukita K#*, et al. Mov Disord 2024
2. Tsukita K#*, et al., Neurology 2023
3. Tsukita K#*, et al. Neurology 2022
4. Tsukita K#*, et al., Mov Disord 2021
5. Tsukita K#*, et al., Mov Disord 2019
<神経超音波関連>
6. Oka Y#, Tsukita K#*, et al., Muscle Nerve 2022
7. Tsukita K#, et al., Parkinsonism Relat Disord 2018
<上皮バリア分子生物学関連>
8. Tsukita K#, et al., Sci Adv 2023
9. Yano T#, Tsukita K#, et al., EMBO J 2021
<その他データ解析関連>
10. Hirata M#, Tsukita K#, et al., Cell Rep Med 2025 (in press)
京都大学大学院医学研究科 臨床神経学 特定助教
帝京大学 先端統合研究機構特任研究員
学歴:
2013年 京都大学医学部医学科 卒業
2022年 京都大学大学院 博士課程 修了
研究:
パーキンソン病を含めた神経疾患全般に対して、大規模コホートやバイオインフォマティクスを駆使しつつ、母の研究室にて従事している上皮バリア分子生物学の実験経験も融合し、「実臨床に役に立つ」 & 「病態を解明する」成果を目指す。
主要論文10編:#筆頭著者, *責任著者
<パーキンソン病関連>
1. Kikuya A#, Tsukita K#*, et al. Mov Disord 2024
2. Tsukita K#*, et al., Neurology 2023
3. Tsukita K#*, et al. Neurology 2022
4. Tsukita K#*, et al., Mov Disord 2021
5. Tsukita K#*, et al., Mov Disord 2019
<神経超音波関連>
6. Oka Y#, Tsukita K#*, et al., Muscle Nerve 2022
7. Tsukita K#, et al., Parkinsonism Relat Disord 2018
<上皮バリア分子生物学関連>
8. Tsukita K#, et al., Sci Adv 2023
9. Yano T#, Tsukita K#, et al., EMBO J 2021
<その他データ解析関連>
10. Hirata M#, Tsukita K#, et al., Cell Rep Med 2025 (in press)
[O-01-1]Comparison of direct aspiration technique alone and combined technique for acute ischemic stroke
Saki Nakashima1, Satoshi Kodama1, Shotaro Aso2, Toshiaki Isogai2,3, Hiroki Matsui4, Kiyohide Fushimi5, Hideo Yasunaga4, Shuhei Egashira6, Yuichiro Shirota1,7, Masashi Hamada1, Tatsushi Toda1 (1.Department of Neurology, Graduate School of Medicine, The University of Tokyo, Japan, 2.Department of Health Services Research, Graduate School of Medicine, Japan, 3.Department of Cardiology, Tokyo Metropolitan Tama Medical Center, Japan, 4.Department of Clinical Epidemiology and Health Economics, School of Public Health, Japan, 5.Department of Health Policy and Informatics, Institute of Science Tokyo Graduate School, Japan, 6.Department of Neurology, Toranomon Hospital, Japan, 7.Department of Clinical Laboratory Medicine, Graduate School of Medicine, Japan)
[O-01-2]Neuroprotectants for Acute Ischemic Stroke: A Systematic Review and Network Meta-Analysis
Mario Jr B. Prado1, Ma Carmela S. Callangan2, Marie Charmaine S. Lukban3, Karen Joy B. Adiao3 (1.University of the Philippines Manila, Philippines, 2.The North Canberra Hospital, Australia, 3.Philippine General Hospital, Philippines)
[O-01-3]OLFACTORY ENSHEATHING CELLS AUGMENT HEMATOMA CLEARANCE IN INTRACEREBRAL HEMORRHAGE INJURY
Hock-kean Liew1,2,3, Wei-fen Hu1,3, Yi-hsuan Tseng4, Chin-feng Hsu5, Qi-jun Huang5, Mei-chun Liu6, Tsui-chin Tu6, Chih-jung Hsu6, Chien-hui Lee2,7, Sheng-tzung Tsai2,7, Cheng-yoong Pang1,2,8 (1.Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, 2.Neuro-Medical Scientific Center, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, 3.PhD Program in Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, 4.Department of Laboratory Medicine and Biotechnology, Tzu Chi University, Hualien, Taiwan, 5.Tzu Chi Senior High School Affiliated with Tzu Chi University, Hualien, Taiwan, 6.Top Medical Biomedical CO., LTD, Yilan, Taiwan, 7.Department of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan, 8.Center of Stem Cell and Precision Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan)
[O-01-4]Fibroblast activation protein regulates TLR-induced inflammation and neuroprotection in ischemia
Nan Ju1, Munehisa Shimamura1,3, Chinyang Chang1, Hiroki Hayashi2, Hironori Nakagami2, Ryuichi Morishita4, Hideki Mochizuki3 (1.Department of Gene and Stem Cell Regenerative Therapy, Osaka University Graduate School of Medicine, Japan, 2.Department of Health Development and Medicine, Osaka University Graduate School of Medicine, Japan, 3.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 4.Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Japan)
[O-01-5]DWI-Positive Lesions in Acute ICH: Pre-BP Lowering Occurrence, SVD Markers, and Clinical Outcomes
Satoshi Hosoki1,2,3, Tomotaka Tanaka1, Soshiro Ogata4, Takehito Kuroda1,5, Satoshi Saito1, Kanta Tanaka5, Kazunori Toyoda5, Masatoshi Koga5, Perminder Sachdev3, Masafumi Ihara1 (1.Department of Neurology, National Cerebral and Cardiovascular Center, Japan, 2.Department of Neurology, Kobe City Medical Center General Hospital, Japan, 3.Centre for Healthy Brain Ageing, University of New South Wales, 4.Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Japan, 5.Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Japan)